Meng‐Zhong Liu

3.8k total citations
51 papers, 1.7k citations indexed

About

Meng‐Zhong Liu is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Otorhinolaryngology. According to data from OpenAlex, Meng‐Zhong Liu has authored 51 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Pulmonary and Respiratory Medicine, 25 papers in Surgery and 16 papers in Otorhinolaryngology. Recurrent topics in Meng‐Zhong Liu's work include Esophageal Cancer Research and Treatment (21 papers), Head and Neck Cancer Studies (16 papers) and Gastric Cancer Management and Outcomes (14 papers). Meng‐Zhong Liu is often cited by papers focused on Esophageal Cancer Research and Treatment (21 papers), Head and Neck Cancer Studies (16 papers) and Gastric Cancer Management and Outcomes (14 papers). Meng‐Zhong Liu collaborates with scholars based in China, United States and Hong Kong. Meng‐Zhong Liu's co-authors include Mian Xi, Jun Ma, Yan‐Ping Mao, Ai-Hua Lin, Ling‐Long Tang, Lei Zhao, Qiao-Qiao Li, Ying Sun, Li-Zhi Liu and Yong-Hong Hu and has published in prestigious journals such as PLoS ONE, Scientific Reports and Clinical Cancer Research.

In The Last Decade

Meng‐Zhong Liu

50 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Meng‐Zhong Liu China 22 785 723 597 495 316 51 1.7k
Stella Y. Tsai Taiwan 19 476 0.6× 373 0.5× 423 0.7× 471 1.0× 157 0.5× 25 1.3k
R. Semrau Germany 23 564 0.7× 478 0.7× 408 0.7× 493 1.0× 110 0.3× 59 1.3k
James Jer‐Min Jian Taiwan 23 842 1.1× 475 0.7× 406 0.7× 778 1.6× 173 0.5× 32 1.9k
Yeon‐Sil Kim South Korea 22 454 0.6× 705 1.0× 507 0.8× 546 1.1× 173 0.5× 110 1.6k
Gabrielle Brown United States 10 224 0.3× 801 1.1× 293 0.5× 382 0.8× 302 1.0× 15 1.4k
R. Le Fur France 11 571 0.7× 664 0.9× 870 1.5× 490 1.0× 98 0.3× 17 1.5k
K.K. Ang United States 15 390 0.5× 508 0.7× 340 0.6× 580 1.2× 302 1.0× 59 1.4k
Mian Xi China 23 893 1.1× 837 1.2× 67 0.1× 503 1.0× 262 0.8× 105 1.6k
Li-Zhi Liu China 23 790 1.0× 552 0.8× 1.2k 2.0× 581 1.2× 135 0.4× 42 1.7k
Keith Unger United States 17 275 0.4× 373 0.5× 114 0.2× 398 0.8× 107 0.3× 64 940

Countries citing papers authored by Meng‐Zhong Liu

Since Specialization
Citations

This map shows the geographic impact of Meng‐Zhong Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meng‐Zhong Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meng‐Zhong Liu more than expected).

Fields of papers citing papers by Meng‐Zhong Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Meng‐Zhong Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meng‐Zhong Liu. The network helps show where Meng‐Zhong Liu may publish in the future.

Co-authorship network of co-authors of Meng‐Zhong Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Meng‐Zhong Liu. A scholar is included among the top collaborators of Meng‐Zhong Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Meng‐Zhong Liu. Meng‐Zhong Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Qiu, Bo, Zhiqiang Wang, Ying Liang, et al.. (2017). Adjuvant Therapy for a Microscopically Incomplete Resection Margin after an Esophagectomy for Esophageal Squamous Cell Carcinoma. Journal of Cancer. 8(2). 249–257. 9 indexed citations
3.
Xi, Mian, Qiao-Qiao Li, Lei Zhao, et al.. (2017). Comparative Outcomes of Induction Chemotherapy Followed By Definitive Chemoradiotherapy versus Chemoradiotherapy Alone In Esophageal Squamous Cell Carcinoma. Journal of Cancer. 8(17). 3441–3447. 16 indexed citations
6.
Zhao, Lei, Feng Chi, Mian Xi, et al.. (2015). Polymorphisms of insulin-like growth factor binding protein-3 as a predictor for risk and patient survival in esophageal squamous cell carcinoma. Biomedicine & Pharmacotherapy. 74. 148–152. 4 indexed citations
8.
Xi, Mian, Li Zhang, Lei Zhao, et al.. (2013). Effectiveness of Stereotactic Body Radiotherapy for Hepatocellular Carcinoma with Portal Vein and/or Inferior Vena Cava Tumor Thrombosis. PLoS ONE. 8(5). e63864–e63864. 110 indexed citations
9.
Sun, Ying, Feng Chi, Rui Guo, et al.. (2013). Evaluation of inter-fraction and intra-fraction errors during volumetric modulated arc therapy in nasopharyngeal carcinoma patients. Radiation Oncology. 8(1). 78–78. 14 indexed citations
10.
Zhao, Lei, Li-Ru He, Mian Xi, et al.. (2012). Nimotuzumab promotes radiosensitivity of EGFR-overexpression esophageal squamous cell carcinoma cells by upregulating IGFBP-3. Journal of Translational Medicine. 10(1). 249–249. 36 indexed citations
11.
Zhao, Lei, Qiao-Qiao Li, Rui Zhang, et al.. (2012). The overexpression of IGFBP-3 is involved in the chemosensitivity of esophageal squamous cell carcinoma cells to nimotuzumab combined with cisplatin. Tumor Biology. 33(4). 1115–1123. 12 indexed citations
12.
Zhao, Lei, Li-Ru He, Rui Zhang, et al.. (2011). Low expression of IGFBP-3 predicts poor prognosis in patients with esophageal squamous cell carcinoma. Medical Oncology. 29(4). 2669–2676. 18 indexed citations
13.
Xi, Mian, Li Zhang, Meng‐Zhong Liu, et al.. (2010). Dosimetric Analysis of Respiratory-Gated Radiotherapy for Hepatocellular Carcinoma. Medical dosimetry. 36(2). 213–218. 9 indexed citations
14.
Xi, Mian, Meng‐Zhong Liu, Qiao-Qiao Li, et al.. (2009). Analysis of abdominal organ motion using four-dimensional CT. Chinese Journal of Cancer. 28(9). 989–993. 12 indexed citations
15.
Mao, Yan‐Ping, Wen-Fei Li, Lei Chen, et al.. (2009). A clinical verification of the Chinese 2008 staging system for nasopharyngeal carcinoma. Chinese Journal of Cancer. 28(10). 1022–1028. 23 indexed citations
16.
Mao, Yan‐Ping, Fang-Yun Xie, Li-Zhi Liu, et al.. (2009). Re-Evaluation of 6th Edition of AJCC Staging System for Nasopharyngeal Carcinoma and Proposed Improvement Based on Magnetic Resonance Imaging. International Journal of Radiation Oncology*Biology*Physics. 73(5). 1326–1334. 224 indexed citations
17.
Xi, Mian, Meng‐Zhong Liu, Li Zhang, et al.. (2009). How many sets of 4DCT images are sufficient to determine internal target volume for liver radiotherapy?. Radiotherapy and Oncology. 92(2). 255–259. 27 indexed citations
18.
He, Li-Ru, Meng‐Zhong Liu, Binkui Li, et al.. (2009). Prognostic impact of H3K27me3 expression on locoregional progression after chemoradiotherapy in esophageal squamous cell carcinoma. BMC Cancer. 9(1). 461–461. 52 indexed citations
19.
Chen, Yong, Meng‐Zhong Liu, Shao-Bo Liang, et al.. (2008). Preliminary Results of a Prospective Randomized Trial Comparing Concurrent Chemoradiotherapy Plus Adjuvant Chemotherapy With Radiotherapy Alone in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma in Endemic Regions of China. International Journal of Radiation Oncology*Biology*Physics. 71(5). 1356–1364. 176 indexed citations
20.
Wu, Yong, Wei-Han Hu, Yun-Fei Xia, et al.. (2006). Quality of life of nasopharyngeal carcinoma survivors in Mainland China. Quality of Life Research. 16(1). 65–74. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026